Report a data issue, formatting problem, or request follow-up. Our team responds within one business day.
Be the first to review this report.
Serology tests are blood-based tests that can be used to identify whether people have been exposed to a particular pathogen by looking at their immune response.These tests can give greater detail into the prevalence of a disease in a population by identifying individuals who have developed antibodies to the virus.
North America is the largest consumption place, with a consumption market share nearly 35.21% in 2020. APAC is the second largest consumption place with the consumption market share of 32.43%.
Market competition is intense. Abbott, Guangzhou Wondfo Biotech, BioMedomics, Kantaro, Roche, etc. are the leaders of the industry. The top 5 companies occupied about half of the market in 2019.
Among the classification of Covid-19 Serology Testing, the proportion of Chemiluminescent Immunoassay in 2020 is about 73.45%.
Covid-19 Serology Testing is widely used for Hospitals and Third-party laboratory. The most proportion of Covid-19 Serology Testing is Hospitals, and the proportion in 2020 is 52.47%.
This report provides an overview of the global Covid-19 Serology Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Covid-19 Serology Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Covid-19 Serology Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Covid-19 Serology Testing market.
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Covid-19 Serology Testing industry.
Chapter 3: Detailed analysis of Covid-19 Serology Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Covid-19 Serology Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Covid-19 Serology Testing in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
You may also be interested in
